{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:29:36Z","timestamp":1790710176166,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.vaccine.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:12:11Z","timestamp":1628532731000},"page":"5368-5375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in Medicare"],"prefix":"10.1016","volume":"39","author":[{"given":"Ravi","family":"Goud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6863-7687","authenticated-orcid":false,"given":"Kerry","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Loc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnstein","family":"Lindaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Arya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoganand","family":"Chillarige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wernecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5138-9373","authenticated-orcid":false,"given":"Thomas E.","family":"MaCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Kelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.004_b0005","first-page":"170","article-title":"Anaphylaxis diagnosis and treatment at an emergency department in Puerto Rico","volume":"32","author":"Calder\u00f3n","year":"2013","journal-title":"P R Health Sci J"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.004_b0010","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999\u20132010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.004_b0015","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.10.029","article-title":"Case fatality and population mortality associated with anaphylaxis in the United States","volume":"133","author":"Ma","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2021.08.004_b0020","doi-asserted-by":"crossref","first-page":"e38563","DOI":"10.1371\/journal.pone.0038563","article-title":"Short and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine","volume":"7","author":"De Serres","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.004_b0025","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal Anaphylaxis: Mortality Rate and Risk Factors","volume":"5","author":"Turner","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.vaccine.2021.08.004_b0030","doi-asserted-by":"crossref","unstructured":"Bann MA, Carrell DS, Gruber S, Shinde M, Ball R, Nelson JC, et al. Identification and Validation of Anaphylaxis Using Electronic Health Data in a Population-based Setting. Epidemiology. 2021;32:439\u201343.","DOI":"10.1097\/EDE.0000000000001330"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.004_b0035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/pds.3505","article-title":"Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel","volume":"22","author":"Walsh","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.004_b0040","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/pds.4877","article-title":"Positive predictive value of ICD-10 codes to detect anaphylaxis due to vaccination: A validation study","volume":"28","author":"Mesfin","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.004_b0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12016-015-8503-x","article-title":"The Epidemiology of Anaphylaxis","volume":"54","author":"Yu","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.004_b0050","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","article-title":"Risk of anaphylaxis after vaccination in children and adults","volume":"137","author":"McNeil","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2021.08.004_b0055","unstructured":"Centers for Medicare & Medicaid Services. MEDICARE BILLING: FORM CMS-1450 AND THE 837 INSTITUTIONAL. Medicare Learning Network; 2018, June."},{"key":"10.1016\/j.vaccine.2021.08.004_b0060","unstructured":"Centers for Medicare & Medicaid Services. MEDICARE PART B IMMUNIZATION BILLING: SEASONAL INFLUENZA VIRUS, PNEUMOCOCCAL, AND HEPATITIS B. Medicare Learning Network; 2018, January."},{"key":"10.1016\/j.vaccine.2021.08.004_b0065","unstructured":"Centers for Medicare & Medicaid Services. MEDICARE PART D VACCINES AND VACCINE ADMINISTRATION. Medicare Learning Network; 2018, January."},{"key":"10.1016\/j.vaccine.2021.08.004_b0070","unstructured":"FLUZONE QUADRIVALENT (Influenza Vaccine) [package insert]. Swiftwater, PA: Sanofi Pasteur Inc.; 2020, July."},{"key":"10.1016\/j.vaccine.2021.08.004_b0075","unstructured":"PNEUMOVAX 23 (Zoster Vaccine Live) [package insert]. Whitehouse Station, NJ: Merck Sharpe & Dohme Corp.; 2019, December."},{"key":"10.1016\/j.vaccine.2021.08.004_b0080","unstructured":"ZOSTAVAX (Zoster Vaccine Live) [package insert]. Whitehouse Station, NJ: Merck Sharpe & Dohme Corp.; 2018, August."},{"key":"10.1016\/j.vaccine.2021.08.004_b0085","unstructured":"PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine) [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals LLC; 2020, March."},{"key":"10.1016\/j.vaccine.2021.08.004_b0090","unstructured":"SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) [package insert]. Research Triangle Park, NC: GlaxoSmithKline Biologicals SA; 2019, June."},{"key":"10.1016\/j.vaccine.2021.08.004_b0095","unstructured":"ADACEL (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed) [package insert]. Swiftwater, PA: Sanofi Pasteur Inc.; 2020, March."},{"key":"10.1016\/j.vaccine.2021.08.004_b0100","unstructured":"ENGERIX-B (Hepatitis B Vaccine) [package insert]. Research Triangle Park, NC: GlaxoSmithkline Biologicals SA; 2018, November."},{"issue":"31","key":"10.1016\/j.vaccine.2021.08.004_b0105","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.004_b0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2013Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.004_b0115","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaci.2011.04.049","article-title":"A population-based epidemiologic study of emergency department visits for anaphylaxis in Florida","volume":"128","author":"Harduar-Morano","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2021.08.004_b0120","first-page":"119","article-title":"Approximate Is Better than \u201cExact\u201d for Interval Estimation of Binomial Proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"The American Statistician"},{"issue":"394","key":"10.1016\/j.vaccine.2021.08.004_b0125","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/01621459.1986.10478280","article-title":"Multiple Imputation for Interval Estimation From Simple Random Samples With Ignorable Nonresponse","volume":"81","author":"Rubin","year":"1986","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.004_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-12-128","article-title":"Positive predictive value of a case definition for diabetes mellitus using automated administrative health data in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid study","volume":"12","author":"Bobo","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.vaccine.2021.08.004_b0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4168\/aair.2020.12.2.359","article-title":"Delayed-Onset Anaphylaxis Caused by IgE Response to Influenza Vaccination","volume":"12","author":"Kim","year":"2020","journal-title":"Allergy Asthma Immunol Res"},{"issue":"5","key":"10.1016\/j.vaccine.2021.08.004_b0140","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.anai.2010.03.004","article-title":"Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system","volume":"104","author":"Iribarren","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"182\u20138","key":"10.1016\/j.vaccine.2021.08.004_b0145","article-title":"Trends, characteristics, and incidence of anaphylaxis in 2001\u20132010: A population-based study","volume":"139","author":"Lee","year":"2017","journal-title":"J Allergy Clin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21010033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:46Z","timestamp":1759402786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21010033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":29,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0264410X21010033"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in Medicare","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}